2021
DOI: 10.1016/j.det.2021.05.014
|View full text |Cite
|
Sign up to set email alerts
|

How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World

Abstract: Coronavirus disease 2019 (COVID-19) brought the world to its knees. As each nation grappled with launching an effective response while simultaneously minimizing repercussions on health care systems, economies, and societies, the medical and scientific landscape shifted forever. In particular, COVID-19 has challenged and transformed the field of dermatology and the way we practice. In this article, dermatologists from 11 countries share insights gained from local experience. These global perspectives will help … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 78 publications
0
3
0
Order By: Relevance
“…Therefore, the number of dermatologic patients who applied to clinics during the pandemic period decreased, and in addition to this decrease, fear of contracting COVID-19 and skin conditions related to COVID-19 (vesicular eruptions, petechial/purpuric rashes, acral lesions, livedoid lesions, urticarial rash, and maculopapular-erythematous rash) changed the profile of faced dermatological diseases [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the number of dermatologic patients who applied to clinics during the pandemic period decreased, and in addition to this decrease, fear of contracting COVID-19 and skin conditions related to COVID-19 (vesicular eruptions, petechial/purpuric rashes, acral lesions, livedoid lesions, urticarial rash, and maculopapular-erythematous rash) changed the profile of faced dermatological diseases [3][4][5].…”
Section: Introductionmentioning
confidence: 99%
“…The University of São Paulo Medical School is a reference center for AIBD, with 1,156 patients under follow-up (683 with pemphigus and 473 with subepidermal blistering diseases). From March until September 2020, our hospital exclusively dedicated 800 beds for the treatment of 4,500 severe COVID-19 cases ( 2 ), which limited dermatological outpatient and inpatient consultations ( 3 ). Such measures led to reschedule AIBD patients in remission and reevaluation of immunosuppressant therapy with the lowest immunosuppression for patients with active disease.…”
Section: Introductionmentioning
confidence: 99%
“…A strong effort to fight against this new disease was required from every physician, and a virtuous collaboration involving all specialties was established [ 1 ]. Physicians routinely predestined to different tasks were redeployed to the frontlines into the COVID departments [ 2 ]. A few months into the crisis, dermatologists began to describe cutaneous manifestations likely related to this virus [ 3 ], and scientists worldwide became aware of this correlation.…”
mentioning
confidence: 99%